Fast, accurate, affordable point of care testing
PhenUTest’s innovative point of care testing has the potential to transform the diagnosis and treatment of urinary track infection (UTI).
The pioneering technology that lies at the heart of PhenUTest has been developed to:
-
Simplify diagnostic procedures by removing the need for any external laboratories
-
Speed up the whole diagnostic process significantly
-
Include detection of any patient antimicrobial resistance (AMR) right from the outset
Fast, accurate, affordable point of care testing
PhenUTest’s innovative point of care testing has the potential to transform the diagnosis and treatment of urinary track infection (UTI).
The pioneering technology that lies at the heart of PhenUTest has been developed to:
-
Simplify diagnostic procedures by removing the need for any external laboratories
-
Speed up the whole diagnostic process significantly
-
Include detection of any patient antimicrobial resistance (AMR) right from the outset
100 million
people are diagnosed
with UTI every year
UTI is a condition for which over 100 million people are diagnosed every year. In the US alone annual costs for treating UTI exceed $45 billion. In the UK, the infection is responsible for more than 22% of the country’s antibiotic prescriptions.
Current UTI testing procedures take 48+ hours. In contrast, PhenUTest’s proprietary technology reduces this to less than an hour for accurate-first-time diagnostics.
100 million
people are diagnosed
with UTI every year
UTI is a condition for which over 100 million people are diagnosed every year. In the US alone annual costs for treating UTI exceed $45 billion. In the UK, the infection is responsible for more than 22% of the country’s antibiotic prescriptions.
Current UTI testing procedures take 48+ hours. In contrast, PhenUTest’s proprietary technology reduces this to less than an hour for accurate-first-time diagnostics.
With the adoption of PhenUTest, in development for use in doctors’ surgeries, pharmacies and care homes, hospitalisation will be reduced, health services will save millions and antimicrobial resistance caused by the prescription of broad spectrum antibiotics will be slowed down.
PhenUTest is a spin out from the University of Liverpool, which is known globally for its AMR research.
With the adoption of PhenUTest, in development for use in doctors’ surgeries, pharmacies and care homes, hospitalisation will be reduced, health services will save millions and antimicrobial resistance caused by the prescription of broad spectrum antibiotics will be slowed down.
PhenUTest is a spin out from the University of Liverpool, which is known globally for its AMR research.
Biosciences Building, Crown Street
Liverpool, L69 7BE, UK
Biosciences Building, Crown Street
Liverpool, L69 7BE, UK